Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Non-Small Cell Lung Cancer
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
170
Start Date:
January 7, 2022
A Randomized, Double-blind, Phase 3 Bridging Study Evaluating the Safety and Efficacy of ABP 215 Compared With Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
116
Start Date:
September 4, 2021
A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug
Participants:
65
Start Date:
July 2, 2021
Phase 1/2 Open-Label, Dose-Escalation and Dose Expansion Study to Determine a CNS Dose and Schedule of Tepotinib Alone or in Combination With Other Relevant Tyrosine Kinase Inhibitors (TKIs) in Adult Participants With MET-Driven NSCLC
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
160
Start Date:
July 1, 2021
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung Cancer
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
198
Start Date:
June 30, 2021
A Phase 1a Open-Label, Dose-Escalation, and a Phase 2 Study to Investigate the Safety, PK, PD, and Clinical Activity of ST-067 Administered Subcutaneously as Monotherapy in Patients With Relapsed or Refractory Solid Tumors
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
30
Start Date:
June 30, 2021
A Pilot Study to Evaluate the Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Dietary Supplement, Drug
Participants:
560
Start Date:
June 2021
A Randomized, Open-Label, Phase 3 Study of Cosibelimab (CK-301) in Combination With Platinum+Pemetrexed Chemotherapy in Subjects With First-Line Metastatic Non-squamous Non-Small Cell Lung Cancer
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug, Biological
Participants:
100
Start Date:
June 2021
A Phase 1/2 Open-Label, Dose-escalation and Clinical Response Study of GPX-001 in Combination With Osimertinib in Patients With Advanced, Metastatic EGFR-mutant Non-small Cell Lung Cancer
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Other, Behavioral
Participants:
10
Start Date:
May 15, 2021
Feasibility of a Perioperative Physical Activity Intervention for Older Adults With Lung Cancer and Their Family Caregivers
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Radiation
Participants:
20
Start Date:
May 4, 2021
Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy of All Body Locations With the Disease at 3 Months After First Line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer, Prior to Maintenance Therapy
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug
Participants:
100
Start Date:
May 1, 2021
A Phase 1/2, Open-label, Study to Investigate the Safety, Tolerability, and Efficacy of SC-43 Administered in Combination With Cisplatin in Subjects With Advanced or Refractory Non-small Cell Lung Cancer or Biliary Tract Carcinoma
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
30
Start Date:
May 2021
A Phase II Trial of Restorative Microbiota Therapy (RMT) in Combination With Durvalumab (MEDI4736) or Durvalumab (MEDI4736) + Chemotherapy in Untreated Patients With Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer
Showing 1-12 of 1485
Next